Month: March 2023

Mar 21 2023

Uncategorized

Karuna/ Zai Lab succeed in late-stage trial for schizophrenia candidate

by Clinical Editor

No Comments

Karuna Therapeutics (KRTX) announced Monday that its lead asset KarXT co-developed with Zai Lab (ZLAB), reached the main goal in a Phase 3 trial for schizophrenia. Read the full story...

Mar 21 2023

Uncategorized

Karuna Stock Jumps on Third Positive Trial for Schizophrenia Drug

by Clinical Editor

No Comments

The biotech said it would seek approval for the drug in the middle of this year and that the drug could be launched in the second half of next year.

Mar 20 2023

Uncategorized

Karuna’s schizophrenia drug meets main goal in late-stage trial

by Clinical Editor

No Comments

Karuna Therapeutics said on Monday its experimental drug significantly reduced symptoms of schizophrenia in a late-stage trial.

Mar 20 2023

Uncategorized

Karuna’s treatment for schizophrenia achieves study goals, bolsters FDA filing plans

by Clinical Editor

No Comments

Karuna Therapeutics said its treatment for schizophrenia reduced psychosis reported by patients — achieving the main goal of a large clinical trial.

Mar 20 2023

Uncategorized

Karuna/ Zai Lab succeed in late-stage trial for schizophrenia candidate

by Clinical Editor

No Comments

Karuna Therapeutics (KRTX) announced Monday that its lead asset KarXT co-developed with Zai Lab (ZLAB), reached the main goal in a Phase 3 trial for schizophrenia. Read the full story...

Mar 20 2023

Uncategorized

Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia

by Clinical Editor

No Comments

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological …

Mar 20 2023

Uncategorized

Karuna: KarXT Hits Key Endpoint in Phase 3 Schizophrenia Study >KRTX

by Clinical Editor

No Comments

By Colin Kellaher Karuna Therapeutics Inc. on Monday said a Phase 3 study of its lead investigational therapy KarXT met its primary endpoint in adults …

Mar 19 2023

Uncategorized

Researchers work to identify new diagnostic tools for schizophrenia

by Clinical Editor

No Comments

The researchers wanted to understand why people who experience schizophrenia report feelings that their senses are being flooded by external stimuli despite the fact that the data, when monitoring the...

Mar 19 2023

Uncategorized

What Do You Want to Know About Schizophrenia?

by Clinical Editor

No Comments

Schizophrenia is a chronic mental health condition. The cause of schizophrenia is unknown but researchers believe it may be caused by a combination of biological, genetic, and environmental factors.

Mar 19 2023

Uncategorized

I Have Schizophrenia. Where’s My Pride Movement?

by Clinical Editor

No Comments

A few months after we met, I made him cry when I shared something with the group: A person in the schizophrenia space who doesn’t have the condition themselves had...